Open AccessAbstract CT033: Efficacy and safety results of pembrolizumab combined with GX-188E, a therapeutic DNA vaccine administration in patients with HPV 16- and/or 18- positive advanced cervical cancer: Phase II interim analysis results
Author(s) -
Soo-Young Hur,
Jong Sup Park,
YongMan Kim,
Myong Cheol Lim,
Jae Hong No,
ByoungGie Kim,
Jae Kwan Lee,
Chi Heum Cho,
Yuyoung Choi,
You Suk Suh,
Jung Won Woo,
Young Chul Sung
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct033
Subject(s) - medicine , pembrolizumab , tolerability , interim analysis , oncology , cervical cancer , chemotherapy , cancer , phases of clinical research , immunotherapy , adverse effect , surgery , clinical trial , gastroenterology